
Quantum-Si (QSI) Stock Forecast & Price Target
Quantum-Si (QSI) Analyst Ratings
Bulls say
Quantum-Si Inc. is poised for a positive financial outlook due to ongoing enhancements to its sequencing consumables and platforms, which are anticipated to facilitate new applications that can drive widespread adoption in the life sciences market. The company's V4 Sequencing Kit is regarded as a significant advancement over its predecessor, V3, and is expected to enable innovative applications such as antibody sequencing, thereby broadening the analytical capabilities for customers. As a result, these developments are projected to significantly increase the utilization levels of Quantum-Si’s Platinum and PlatinumPro instruments, supporting the company's growth trajectory in the proteomics research tools sector.
Bears say
Quantum-Si Inc faces significant operational challenges, including a competitive landscape populated by established companies that may hinder market penetration and growth. The company has a history of operating losses, with this trend expected to persist, raising concerns about its financial sustainability. Additionally, uncertainties surrounding the commercial launch of its products, dependence on third-party manufacturing, and unproven technology further exacerbate the risks associated with its long-term viability in the proteomics research sector.
This aggregate rating is based on analysts' research of Quantum-Si and is not a guaranteed prediction by Public.com or investment advice.
Quantum-Si (QSI) Analyst Forecast & Price Prediction
Start investing in Quantum-Si (QSI)
Order type
Buy in
Order amount
Est. shares
0 shares